)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
AtriCure
AtriCure (ATRC) investor relations material
AtriCure Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary3 Nov, 2026
Executive summary
Q3 revenue was $154.5M, up 15% YoY (15.1% in constant currency); net income was $4.1M versus a $0.3M loss a year earlier.
Adjusted EBITDA rose 50.6% YoY to $26.8M; U.S. demand and product adoption drove growth, while international markets remained slower.
Financial highlights
Gross profit was $119.4M versus $101.3M; gross margin expanded 180 bps YoY to 77.3% on favorable product and geographic mix.
Operating expenses were $115M, up 13.7%; excluding a $4.5M PFA co-development milestone, expenses rose 9.3%. SG&A rose 5.9%, while R&D increased 20.6% excluding the milestone.
Operating income was $4.4M versus $0.2M; GAAP diluted EPS was $0.08 versus a $0.01 loss, and adjusted EPS was $0.18 versus a $0.01 loss.
Nine-month revenue was $449.3M versus $394.0M; net income was $13.1M versus a $13.2M loss, and adjusted EBITDA was $71.2M versus $41.9M.
Outlook and guidance
FY2026 revenue guidance is $606M-$610M, representing 13.4%-14.1% annual growth; management expects to finish ahead of initial guidance.
Adjusted EBITDA guidance increased to $91M-$94M; FY2026 GAAP EPS guidance is $0.21-$0.27 and adjusted EPS is $0.40-$0.46.
FY2026 gross margin is expected in the upper 76% range; full-quarter new-facility costs and product or geographic mix may pressure quarterly margins.
Q4 guidance reflects prudence amid sustained U.S. hybrid ablation and international headwinds; continued positive cash generation is expected.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AtriCure
- Clinical and financial progress outpace targets, with innovation and market expansion driving growth.ATRC
Wells Fargo 21st Annual Healthcare Conference - Strong growth, innovation, and clinical trial catalysts drive robust financial and market expansion.ATRCCanaccord Genuity's 46th Annual Growth Conference
- Q2 2026 revenue up 12.8% to $153.6M, with net income of $9M and margin expansion.ATRCQ2 2026
- Targeting $1B revenue by 2030 through innovation, clinical data, and market expansion.ATRCGoldman Sachs 47th Annual Global Healthcare Conference 2026
- All proposals and board nominees were approved with strong shareholder participation.ATRCAGM 2026
- 2026 growth driven by innovation, exclusive clinical data, and expanding market opportunities.ATRCBank of America Global Healthcare Conference 2026
- Q2 2025 revenue up 17.1% year-over-year, with improved profitability and raised outlook.ATRCQ2 2025
- Aiming for $1B+ revenue by 2030 through innovation and expanded clinical adoption.ATRCInvestor Day 2025
- Double-digit revenue and EBITDA growth in 2024, with robust 2025 outlook and product momentum.ATRCQ4 2024
Next AtriCure earnings date
UBS Global Healthcare Conference9 Nov, 2026
AtriCure
Next AtriCure earnings date
UBS Global Healthcare Conference9 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
AtriCure Inc develops and sells medical devices for the surgical treatment of atrial fibrillation and related conditions. The company offers ablation systems, surgical instruments, and cryoablation technologies used in both open-heart and minimally invasive procedures. The company is headquartered in Mason, Ohio, and its shares are listed on the NASDAQ.